Items where authors include "McCann, C."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Fish, R. orcid.org/0000-0002-4239-6993, Blackwell, S. orcid.org/0000-0002-2819-3727, Knight, S.R. orcid.org/0000-0003-0448-3719 et al. (308 more authors) (2024) Defining standards and core outcomes for clinical trials in prehabilitation for colorectal surgery (DiSCO): modified Delphi methodology to achieve patient and healthcare professional consensus. British Journal of Surgery, 111 (6). znae056. ISSN 0007-1323

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Ghafari, M. orcid.org/0000-0002-4123-3287, Hall, M. orcid.org/0000-0002-2671-3864, Golubchik, T. orcid.org/0000-0003-2765-9828 et al. (30 more authors) (2024) Prevalence of persistent SARS-CoV-2 in a large community surveillance study. Nature, 626 (8001). pp. 1094-1101. ISSN 0028-0836

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Rangelov, B. orcid.org/0000-0001-7017-1575, Young, A. orcid.org/0000-0002-7772-781X, Lilaonitkul, W. et al. (145 more authors) (2023) Author Correction: Delineating COVID-19 subgroups using routine clinical data identifies distinct in-hospital outcomes. Scientific Reports, 13. 18376. ISSN 2045-2322

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Rangelov, B. orcid.org/0000-0001-7017-1575, Young, A. orcid.org/0000-0002-7772-781X, Lilaonitkul, W. et al. (97 more authors) (2023) Delineating COVID-19 subgroups using routine clinical data identifies distinct in-hospital outcomes. Scientific Reports, 13. 9986. ISSN 2045-2322

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Williams, D.J., Archer, R., Archibald, P. et al. (46 more authors) (2016) Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015. Regenerative Medicine, 11 (5). pp. 483-492. ISSN 1746-0751

Proceedings Paper

Frith, T.J.R., McCann, C., Gogolou, A. et al. (4 more authors) (2019) Transplantation of hPSC derived enteric neural progenitors as a basis to derive a preclinical cell therapy for Hirschsprung's disease. In: Human Gene Therapy. Annual Conference of the British Society for Gene and Cell Therapy, 19-21 Jun 2019, Sheffield, UK. , P02-P02.